Todos Medical Ltd.
TOMDF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $2 | $2 |
| % Growth | -26.7% | -12.2% | -0.9% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 100% | 33.4% | 53% | 40.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $2 | $3 | $3 |
| SG&A Expenses | $3 | $2 | $3 | $4 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $2 | $3 | $4 |
| Operating Income | -$2 | -$2 | -$2 | -$3 |
| % Margin | -146% | -90.6% | -84% | -153.7% |
| Other Income/Exp. Net | -$3 | -$4 | -$5 | -$4 |
| Pre-Tax Income | -$5 | -$6 | -$7 | -$8 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$6 | -$7 | -$9 |
| % Margin | -355.9% | -312.5% | -333.1% | -387.5% |
| EPS | -0.004 | -0.005 | -0.006 | -0.012 |
| % Growth | 25.5% | 21.7% | 48.3% | – |
| EPS Diluted | -0.004 | -0.005 | -0.006 | -0.012 |
| Weighted Avg Shares Out | 1,426 | 1,280 | 1,200 | 737 |
| Weighted Avg Shares Out Dil | 1,426 | 1,280 | 1,200 | 737 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $3 |
| Interest Expense | $3 | $3 | $4 | $6 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$2 | -$2 | -$1 |
| % Margin | -134.2% | -113.4% | -114.6% | -41.1% |